Bella Casa Fashion & Retail Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 6, 2025, 4:33 pm

Competitors of Bella Casa Fashion & Retail Ltd

All Competitor Stocks of Bella Casa Fashion & Retail Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:30 pm

Below is a detailed analysis of the quarterly data for Bella Casa Fashion & Retail Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 89.91 Cr.. The value appears strong and on an upward trend. It has increased from 87.08 Cr. (Mar 2025) to 89.91 Cr., marking an increase of 2.83 Cr..
• For Expenses, as of Jun 2025, the value is 82.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.92 Cr. (Mar 2025) to 82.52 Cr., marking an increase of 1.60 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.39 Cr.. The value appears strong and on an upward trend. It has increased from 6.16 Cr. (Mar 2025) to 7.39 Cr., marking an increase of 1.23 Cr..
• For OPM %, as of Jun 2025, the value is 8.22%. The value appears strong and on an upward trend. It has increased from 7.07% (Mar 2025) to 8.22%, marking an increase of 1.15%.
• For Other Income, as of Jun 2025, the value is 0.76 Cr.. The value appears strong and on an upward trend. It has increased from 0.50 Cr. (Mar 2025) to 0.76 Cr., marking an increase of 0.26 Cr..
• For Interest, as of Jun 2025, the value is 0.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.60 Cr. (Mar 2025) to 0.93 Cr., marking an increase of 0.33 Cr..
• For Depreciation, as of Jun 2025, the value is 0.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.81 Cr. (Mar 2025) to 0.92 Cr., marking an increase of 0.11 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.30 Cr.. The value appears strong and on an upward trend. It has increased from 5.25 Cr. (Mar 2025) to 6.30 Cr., marking an increase of 1.05 Cr..
• For Tax %, as of Jun 2025, the value is 25.40%. The value appears to be increasing, which may not be favorable. It has increased from 17.33% (Mar 2025) to 25.40%, marking an increase of 8.07%.
• For Net Profit, as of Jun 2025, the value is 4.70 Cr.. The value appears strong and on an upward trend. It has increased from 4.34 Cr. (Mar 2025) to 4.70 Cr., marking an increase of 0.36 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.51. The value appears strong and on an upward trend. It has increased from 3.24 (Mar 2025) to 3.51, marking an increase of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:48 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: August 11, 2025, 3:28 pm

Below is a detailed analysis of the balance sheet data for Bella Casa Fashion & Retail Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2024) to 136.00 Cr., marking an increase of 63.00 Cr..
• For Borrowings, as of Mar 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 43.00 Cr. (Mar 2024) to 31.00 Cr., marking a decrease of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing). It has decreased from 33.00 Cr. (Mar 2024) to 32.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 52.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 18.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Mar 2024) to 176.00 Cr., marking an increase of 34.00 Cr..
• For Total Assets, as of Mar 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 161.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 52.00 Cr..

Notably, the Reserves (136.00 Cr.) exceed the Borrowings (31.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bella Casa Fashion & Retail Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.43. This value is within the healthy range. It has increased from 8.89 (Mar 24) to 12.43, marking an increase of 3.54.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.43. This value is within the healthy range. It has increased from 8.89 (Mar 24) to 12.43, marking an increase of 3.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.99. This value is within the healthy range. It has increased from 10.52 (Mar 24) to 13.99, marking an increase of 3.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.69. It has increased from 73.97 (Mar 24) to 111.69, marking an increase of 37.72.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.69. It has increased from 73.97 (Mar 24) to 111.69, marking an increase of 37.72.
• For Dividend / Share (Rs.), as of Mar 25, the value is 2.00. This value is within the healthy range. It has increased from 1.77 (Mar 24) to 2.00, marking an increase of 0.23.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 260.35. It has increased from 200.52 (Mar 24) to 260.35, marking an increase of 59.83.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 22.08. This value is within the healthy range. It has increased from 16.85 (Mar 24) to 22.08, marking an increase of 5.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 19.89. This value is within the healthy range. It has increased from 15.21 (Mar 24) to 19.89, marking an increase of 4.68.
• For PBT / Share (Rs.), as of Mar 25, the value is 15.90. This value is within the healthy range. It has increased from 11.83 (Mar 24) to 15.90, marking an increase of 4.07.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.80. This value is within the healthy range. It has increased from 8.87 (Mar 24) to 11.80, marking an increase of 2.93.
• For PBDIT Margin (%), as of Mar 25, the value is 8.48. This value is below the healthy minimum of 10. It has increased from 8.40 (Mar 24) to 8.48, marking an increase of 0.08.
• For PBIT Margin (%), as of Mar 25, the value is 7.63. This value is below the healthy minimum of 10. It has increased from 7.58 (Mar 24) to 7.63, marking an increase of 0.05.
• For PBT Margin (%), as of Mar 25, the value is 6.10. This value is below the healthy minimum of 10. It has increased from 5.89 (Mar 24) to 6.10, marking an increase of 0.21.
• For Net Profit Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 5. It has increased from 4.42 (Mar 24) to 4.53, marking an increase of 0.11.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.56. This value is below the healthy minimum of 15. It has decreased from 11.99 (Mar 24) to 10.56, marking a decrease of 1.43.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.36. This value is within the healthy range. It has decreased from 20.12 (Mar 24) to 16.36, marking a decrease of 3.76.
• For Return On Assets (%), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.31 (Mar 24) to 7.41, marking an increase of 1.10.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.49 (Mar 24) to 0.12, marking a decrease of 0.37.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.86. It has increased from 1.51 (Mar 24) to 1.86, marking an increase of 0.35.
• For Current Ratio (X), as of Mar 25, the value is 3.35. This value exceeds the healthy maximum of 3. It has increased from 1.91 (Mar 24) to 3.35, marking an increase of 1.44.
• For Quick Ratio (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from 0.54 (Mar 24) to 1.32, marking an increase of 0.78.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.42. This value is below the healthy minimum of 4. It has increased from 1.10 (Mar 24) to 3.42, marking an increase of 2.32.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.04. This value is below the healthy minimum of 20. It has decreased from 9.01 (Mar 24) to 7.04, marking a decrease of 1.97.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.94. This value is below the healthy minimum of 20. It has decreased from 7.60 (Mar 24) to 5.94, marking a decrease of 1.66.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.96. This value exceeds the healthy maximum of 70. It has increased from 90.99 (Mar 24) to 92.96, marking an increase of 1.97.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.06. This value exceeds the healthy maximum of 70. It has increased from 92.40 (Mar 24) to 94.06, marking an increase of 1.66.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 4.99 (Mar 24) to 5.54, marking an increase of 0.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.96. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 3.96, marking an increase of 0.33.
• For Enterprise Value (Cr.), as of Mar 25, the value is 547.01. It has increased from 386.41 (Mar 24) to 547.01, marking an increase of 160.60.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 1.57, marking a decrease of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 18.51. This value exceeds the healthy maximum of 15. It has decreased from 19.98 (Mar 24) to 18.51, marking a decrease of 1.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 1.56, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 92.95. This value exceeds the healthy maximum of 70. It has increased from 90.98 (Mar 24) to 92.95, marking an increase of 1.97.
• For Price / BV (X), as of Mar 25, the value is 3.64. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.64, marking a decrease of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 1.56, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness